Entity Common Stock, Shares Outstanding of Yubo International Biotech Ltd from 25 May 2012 to 13 Nov 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Yubo International Biotech Ltd quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 25 May 2012 to 13 Nov 2025.
  • Yubo International Biotech Ltd Entity Common Stock, Shares Outstanding for the quarter ending 13 Nov 2025 was 170,416,343, a 42% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Yubo International Biotech Ltd Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 170,416,343 +50,600,000 +42% 13 Nov 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 170,416,343 +50,600,000 +42% 13 Aug 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 119,816,343 0 0% 31 Mar 2025 10-K 31 Mar 2025 2024 FY
Q3 2024 119,816,343 10 Nov 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 119,816,343 0 0% 17 May 2024 10-Q 20 May 2024 2024 Q1
Q1 2024 119,816,343 0 0% 12 Apr 2024 10-K 12 Apr 2024 2023 FY
Q4 2023 119,816,343 0 0% 19 Nov 2023 10-Q 20 Nov 2023 2023 Q3
Q2 2023 119,816,343 +1,638,458 +1.4% 04 Aug 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 119,816,343 +1,638,458 +1.4% 13 Apr 2023 10-K 14 Apr 2023 2022 FY
Q4 2022 119,816,343 15 Nov 2022 10-Q 16 Nov 2022 2022 Q3
Q2 2022 118,177,885 0 0% 12 Aug 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 118,177,885 0 0% 14 Apr 2022 10-K 15 Apr 2022 2021 FY
Q3 2021 118,177,885 +301,123 +0.26% 19 Aug 2021 10-Q 15 Nov 2021 2021 Q2
Q2 2021 118,177,885 +116,999,123 +9926% 21 May 2021 10-Q 24 May 2021 2021 Q1
Q1 2021 118,177,885 23 Apr 2021 10-KT 23 Apr 2021 2020 FY
Q4 2020 118,177,885 19 Jan 2021 10-Q 19 Jan 2021 2021 Q3
Q3 2020 117,876,762 +116,698,000 +9900% 02 Oct 2020 10-Q 20 Oct 2020 2021 Q2
Q2 2020 1,178,762 0 0% 14 Jul 2020 10-Q 20 Jul 2020 2021 Q1
Q3 2019 1,178,762 0 0% 10 Oct 2019 10-Q 13 Jan 2020 2020 Q3
Q2 2019 1,178,762 -567 -0.05% 10 Jul 2019 10-Q 11 Jul 2019 2020 Q1
Q4 2018 1,178,762 0 0% 08 Jan 2019 10-Q 11 Jan 2019 2019 Q3
Q3 2018 1,178,762 0 0% 05 Oct 2018 10-Q 12 Oct 2018 2019 Q2
Q2 2018 1,179,329 +567 +0.05% 13 Jul 2018 10-Q 16 Jul 2018 2019 Q1
Q4 2017 1,178,762 -567 -0.05% 12 Jan 2018 10-Q 16 Jan 2018 2018 Q3
Q3 2017 1,178,762 -567 -0.05% 13 Oct 2017 10-Q 16 Oct 2017 2018 Q2
Q2 2017 1,178,762 -567 -0.05% 11 Jul 2017 10-Q 14 Jul 2017 2018 Q1
Q4 2016 1,179,329 +2,956 +0.25% 15 Dec 2016 10-Q 13 Jan 2017 2017 Q3
Q3 2016 1,179,329 +2,956 +0.25% 30 Sep 2016 10-Q 12 Oct 2016 2017 Q2
Q2 2016 1,179,329 +2,956 +0.25% 30 Jun 2016 10-Q 12 Jul 2016 2017 Q1
Q4 2015 1,176,373 +348 +0.03% 08 Jan 2016 10-Q 14 Jan 2016 2016 Q3
Q3 2015 1,176,373 -2,956 -0.25% 30 Sep 2015 10-Q 06 Oct 2015 2016 Q2
Q2 2015 1,176,373 -2,956 -0.25% 30 Jun 2015 10-Q 09 Jul 2015 2016 Q1
Q4 2014 1,176,025 -304 -0.03% 09 Jan 2015 10-Q 14 Jan 2015 2015 Q3
Q3 2014 1,179,329 0 0% 03 Oct 2014 10-Q 17 Oct 2014 2015 Q2
Q2 2014 1,179,329 0 0% 16 Jun 2014 10-Q 23 Jun 2014 2015 Q1
Q4 2013 1,176,329 -3,000 -0.25% 06 Jan 2014 10-Q 13 Jan 2014 2013 Q3
Q3 2013 1,179,329 23 Sep 2013 10-Q 03 Oct 2013 2013 Q2
Q2 2013 1,179,329 +3,304 +0.28% 10 Jul 2013 10-Q 15 Jul 2013 2013 Q1
Q4 2012 1,179,329 10 Jan 2013 10-Q 16 Jan 2013 2012 Q3
Q2 2012 1,176,025 25 May 2012 10-K 11 Jun 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.